normative

Accounting Mindset Threatens Pharma Breakthroughs

Overreliance on an accounting-type mindset in pharma is dangerous, because commercial functions should serve R&D, and when managers focused on milking existing products dominate, breakthroughs like Keytruda and GLP-1 agonists become less likely.

normativepending

Speaker

Alex

Evidence Quote

“The commercial parts of big pharma should be in service to the R&D portion of the organizations or the ecosystem.”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...